Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, et al. Sjögren’s syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1): e000789. https://doi.org/10.1136/rmdopen-2018-000789.
Article PubMed PubMed Central Google Scholar
Nocturne G, Mariette X. Sjögren syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168(3):317–27. https://doi.org/10.1111/bjh.13192.
Article CAS PubMed Google Scholar
Zhang Q, Wang X, Chen H, Shen B. Sjögren’s syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from Short Form 36 questionnaire and a meta-analysis. Patient Prefer Adher. 2017;11:905–11. https://doi.org/10.2147/ppa.S132751.
Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjögren’s syndrome: results from a cohort study. Rheumatology. 2012;51(2):262–9. https://doi.org/10.1093/rheumatology/ker208.
Komori K, Komori M, Horino T, Nishiyama S, Takei M, Suganuma N. Factors associated with delayed diagnosis of Sjögren’s syndrome among members of the Japanese Sjögren’s association for patients. Clin Exp Rheumatol. 2021;39(6):146–52. https://doi.org/10.55563/clinexprheumatol/s8l2n0.
Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren’s syndrome: results of a prospective concerted action supported by the European community. Arthr Rheum. 1993;36(3):340–7. https://doi.org/10.1002/art.1780360309.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8. https://doi.org/10.1136/ard.61.6.554.
Article CAS PubMed PubMed Central Google Scholar
Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthr Care Res. 2012;64(4):475–87. https://doi.org/10.1002/acr.21591.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthr Rheumatol. 2017;69(1):35–45. https://doi.org/10.1002/art.39859.
Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 2014;6:247–55. https://doi.org/10.2147/clep.S47399.
Article PubMed PubMed Central Google Scholar
Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983–9. https://doi.org/10.1136/annrheumdis-2014-205375.
Article CAS PubMed Google Scholar
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Available at: www.training.cochrane.org/handbook [Last accessed: November 2021]. 2019.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41. https://doi.org/10.1016/j.ijsu.2010.02.007.
Sjögren’s Foundation: Language Matters - Let your voice be heard! Available from: https://www.Sjögrens.org/news/2022/language-matters-let-your-voice-be-heard [Last Accessed: October 2022]. 2022.
Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, et al. EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015;1(1): e000022.
Article PubMed PubMed Central Google Scholar
Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjögren’s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjögren’s syndrome. Ann Rheum Dis. 2011;70(6):968–72.
Centre for Reviews and Dissemination. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of York, York, 2008.
Joanna Briggs Institute: Critical Appraisal Tools. Available from: https://jbi.global/critical-appraisal-tools [Last Accessed: April 2022].
Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, et al. Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 2019. https://doi.org/10.1136/rmdopen-2019-001033.
Article PubMed PubMed Central Google Scholar
Abrol E, Gonzalez-Pulido C, Praena-Fernandez JM, Isenberg DA. A retrospective study of long-term outcomes in 152 patients with primary Sjögren’s syndrome: 25-year experience. Clin Med. 2014;14(2):157–64. https://doi.org/10.7861/clinmedicine.14-2-157.
Avina-Zubieta JA, Jansz M, Sayre EC, Choi HK. The risk of deep venous thrombosis and pulmonary embolism in primary Sjögren syndrome: A general population-based study. J Rheumatol. 2017;44(8):1184–9. https://doi.org/10.3899/jrheum.160185.
Article PubMed PubMed Central Google Scholar
Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthr Rheum. 2011;63(3):633–9. https://doi.org/10.1002/art.30155.
Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, et al. The incidence and prevalence of adult primary Sjögren’s syndrome in New York County. Arthr Care Res. 2019;71(7):949–60. https://doi.org/10.1002/acr.23707.
Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and mortality of physician-diagnosed primary Sjögren syndrome: time trends over a 40-year period in a population-based US cohort. Mayo Clin Proc. 2017;92(5):734–43. https://doi.org/10.1016/j.mayocp.2017.01.020.
Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjögren’s syndrome 1976–2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013. https://doi.org/10.1136/bmjopen-2013-003569.
Article PubMed PubMed Central Google Scholar
Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O’Fallon WM, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76(6):593–9. https://doi.org/10.4065/76.6.593.
Article CAS PubMed Google Scholar
Seror R, Chiche L, Desjeux G, Zhuo J, Bregman B, Vannier-Moreau V, et al. POS0024 Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study. Ann Rheum Dis. 2021;80(Suppl 1):214–5. https://doi.org/10.1136/annrheumdis-2021-eular.78.
Cortes JB, Gascon TG, Vasallo MDE, Del Cura GI, Rodriguez JAL, Zoni AC, et al. Prevalence of Sjögren’s syndrome in the community of Madrid. Ann Rheum Dis. 2019;78(Supplement 2):791–2. https://doi.org/10.1136/annrheumdis-2019-eular.3949.
Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, et al. Primary and secondary surveys on epidemiology of Sjögren’s syndrome in Japan. Mod Rheumatol. 2014;24(3):464–70. https://doi.org/10.3109/14397595.2013.843765.
Devauchelle Pensec V, Chiche L, Zhuo J, Lavrard I, Desjeux G, Seror R. Development of an algorithm to identify Sjögren’s syndrome patients. Arthr Rheumatol. 2019;71(10):111.
Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sjögren’s syndrome in a US population-based cohort. Arthr Care Res. 2017;69(10):1612–6. https://doi.org/10.1002/acr.23173.
Narvaez J, Sanchez-Fernandez SA, Seoane-Mato D, Diaz-Gonzalez F, Bustabad S. Prevalence of Sjögren’s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases. Sci Rep. 2020;10(1):10627. https://doi.org/10.1038/s41598-020-67462-z.
Article CAS PubMed PubMed Central Google Scholar
Valim V, Zandonade E, Pereira AM, de Brito Filho OH, Serrano EV, Musso C, et al. Primary Sjögren’s syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol. 2013;53(1):24–34.
Zhang N. Epidemiological study of primary Sjögren’s syndrome in China. J Rheumatol. 1995;108(10):787–8.
Gondran G, Fauchais A, Lambert M, Ly K, Launay D, Queyrel V, et al. Primary Sjögren’s syndrome in men. Scand J Rheumatol. 2008;37(4):300–5. https://doi.org/10.1080/03009740802001426.
Article CAS PubMed Google Scholar
Yan S, Li M, Wang H, Yang X, Zhao J, Wang Q, et al. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2018;21(5):1068–75. https://doi.org/10.1111/1756-185X.13290.
Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F, et al. Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine. 2011;78(2):171–4. https://doi.org/10.1016/j.jbspin.2010.05.008.
Retamozo S, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, et al. How the age at diagnosis modifies the phenotype of primary Sjögren syndrome: analysis in 11,420 patients (Big Data Sjögren Project). Ann Rheum Dis. 2019;78:416–7.
Brito-Zeron P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017;76(6):1042–50. https://doi.org/10.1136/annrheumdis-2016-209952.
Cervera R, Font J, Ramos-Casals M, García-Carrasco M, Rosas J, Morlà R, et al. Primary Sjögren’s syndrome in men: clinical and immunological characteristics. Lupus. 2000;9(1):61–4. https://doi.org/10.1177/096120330000900111.
Comments (0)